{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:11:03Z","timestamp":1788210663526,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["ZonMw Efficiency Studies Grant Number 843001801"],"award-info":[{"award-number":["ZonMw Efficiency Studies Grant Number 843001801"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-12195-8","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:38:44Z","timestamp":1766583524000},"page":"3396-3405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cost-effectiveness of contrast-enhanced mammography compared to conventional imaging in the work-up after screening (RACER trial)"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2598-6219","authenticated-orcid":false,"given":"Lidewij M. F. H.","family":"Neeter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B. I.","family":"Lobbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya M.","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P. J. Frank","family":"Raat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein L.","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim E.","family":"Wildberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte A. B.","family":"Essers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"12195_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ijc.30754","volume":"141","author":"VDV Sankatsing","year":"2017","unstructured":"Sankatsing VDV, van Ravesteyn NT, Heijnsdijk EAM et al (2017) The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up. Int J Cancer 141:671\u2013677","journal-title":"Int J Cancer"},{"key":"12195_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1148\/radiol.2018171539","volume":"288","author":"ES Burnside","year":"2018","unstructured":"Burnside ES, Vulkan D, Blanks RG, Duffy SW (2018) Association between screening mammography recall rate and interval cancers in the UK breast cancer service screening program: a cohort study. Radiology 288:47\u201354","journal-title":"Radiology"},{"key":"12195_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2214\/AJR.17.19229","volume":"211","author":"CS Lee","year":"2018","unstructured":"Lee CS, Parise C, Burleson J, Seidenwurm D (2018) Assessing the recall rate for screening mammography: comparing the medicare hospital compare dataset with the national mammography database. Am J Roentgenol 211:127\u2013132","journal-title":"Am J Roentgenol"},{"key":"12195_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/09691413221098839","volume":"29","author":"JE Thy","year":"2022","unstructured":"Thy JE, Vigeland E, Larsen M, Hofvind S (2022) Participation and cancer detection after reminders versus ordinary invitations in BreastScreen Norway. J Med Screen 29:178\u2013184","journal-title":"J Med Screen"},{"key":"12195_CR5","unstructured":"National Institute for Public Health and the Environment (RIVM) (2021) Bevolkingsonderzoek borstkanker\u2014factsheet 2021. https:\/\/www.rivm.nl\/documenten\/factsheet-borstkanker. Accessed 7 Sept 2025"},{"key":"12195_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100987","volume":"44","author":"LMFH Neeter","year":"2024","unstructured":"Neeter LMFH, Nelemans PJ, Raat HPJ et al (2024) Contrast-enhanced mammography versus conventional imaging in women recalled from breast cancer screening (RACER trial): a multicenter, open-label, randomised controlled clinical trial. Lancet Region Health Eur 44:100987. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100987","journal-title":"Lancet Region Health Eur"},{"key":"12195_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3867-5","volume":"20","author":"LMFH Neeter","year":"2019","unstructured":"Neeter LMFH, Houben IPL, Nelemans PJ et al (2019) Rapid access to contrast-enhanced spectral mammography in women recalled from breast cancer screening: the RACER trial study design. Trials 20:759. https:\/\/doi.org\/10.1186\/s13063-019-3867-5","journal-title":"Trials"},{"key":"12195_CR8","unstructured":"GE Healthcare (2011) GE Healthcare announces FDA 510(k) clearance of SenoBright Contrast Enhanced Spectral Mammography (CESM) for breast cancer diagnosis. https:\/\/www.ge.com\/news\/press-releases\/ge-healthcare-announces-fda-510k-clearance-senobright-contrast-enhanced-spectral. Accessed 7 Sept 2025"},{"key":"12195_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13244-019-0756-0","volume":"10","author":"M Zanardo","year":"2019","unstructured":"Zanardo M, Cozzi A, Trimboli RM et al (2019) Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review. Insights Imaging 10:76. https:\/\/doi.org\/10.1186\/s13244-019-0756-0","journal-title":"Insights Imaging"},{"key":"12195_CR10","first-page":"1668","volume":"24","author":"MBI Lobbes","year":"2014","unstructured":"Lobbes MBI, Lalji U, Houwers J et al (2014) Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme. Eur Radiol 24:1668\u20131676","journal-title":"Eur Radiol"},{"key":"12195_CR11","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1007\/s00330-016-4336-0","volume":"26","author":"UC Lalji","year":"2016","unstructured":"Lalji UC, Houben IPL, Prevos R et al (2016) Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study. Eur Radiol 26:4371\u20134379","journal-title":"Eur Radiol"},{"key":"12195_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejrad.2017.07.004","volume":"94","author":"IPL Houben","year":"2017","unstructured":"Houben IPL, van de Voorde P, Jeukens CRLPN et al (2017) Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits. Eur J Radiol 94:31\u201337","journal-title":"Eur J Radiol"},{"key":"12195_CR13","unstructured":"Dutch National Health Care Institute (2016) Guideline for economic evaluations in healthcare. Dutch National Health Care Institute"},{"key":"12195_CR14","unstructured":"Hakkaart-van Roijen L, van der Linden N, Bouwmans C, Kanters T, Tan SS (2016) Costing manual: methods and reference prices for economic evaluations in healthcare. Dutch National Health Care Institute"},{"key":"12195_CR15","unstructured":"EuroQol Research Foundation (2015) EQ-5D-5L User Guide: basic information on how to use the EQ-5D-5L instrument. https:\/\/euroqol.org. 7 Sept 2025"},{"key":"12195_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","volume":"19","author":"MM Versteegh","year":"2016","unstructured":"Versteegh MM, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA (2016) Dutch tariff for the five-level version of EQ-5D. Value Health 19:343\u2013352","journal-title":"Value Health"},{"key":"12195_CR17","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","volume":"32","author":"R Faria","year":"2014","unstructured":"Faria R, Gomes M, Epstein D, White IR (2014) A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics 32:1157\u20131170","journal-title":"Pharmacoeconomics"},{"key":"12195_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1191\/0962280202sm304ra","volume":"11","author":"BJ O\u2019Brien","year":"2002","unstructured":"O\u2019Brien BJ, Briggs AH (2002) Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 11:455\u2013468","journal-title":"Stat Methods Med Res"},{"key":"12195_CR19","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.jacc.2008.09.018","volume":"52","author":"DJ Cohen","year":"2008","unstructured":"Cohen DJ, Reynolds MR (2008) Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol 52:2119\u20132126","journal-title":"J Am Coll Cardiol"},{"key":"12195_CR20","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00330-012-2409-2","volume":"22","author":"JMH Timmers","year":"2012","unstructured":"Timmers JMH, van Doorne-Nagtegaal HJ, Zonderland HM et al (2012) The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool. Eur Radiol 22:1717\u20131723","journal-title":"Eur Radiol"},{"key":"12195_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/hec.584","volume":"10","author":"AH Briggs","year":"2001","unstructured":"Briggs AH, Brien BJO (2001) The death of cost-minimization analysis?. Health Econ 10:179\u2013184","journal-title":"Health Econ"},{"key":"12195_CR22","unstructured":"Zwaap J, Knies S, van der Meijden C, Staal P, van der Heiden L (2015) Cost-effectiveness in practice. Dutch National Health Care Institute"},{"key":"12195_CR23","doi-asserted-by":"publisher","first-page":"W267","DOI":"10.2214\/AJR.17.19355","volume":"211","author":"V Sorin","year":"2018","unstructured":"Sorin V, Yagil Y, Yosepovich A et al (2018) Contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. AJR Am J Roentgenol 211:W267\u2013W274","journal-title":"AJR Am J Roentgenol"},{"key":"12195_CR24","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1177\/0284185118822639","volume":"60","author":"IPL Houben","year":"2019","unstructured":"Houben IPL, Vanwetswinkel S, Kalia V et al (2019) Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management. Acta Radiol 60:1110\u20131117","journal-title":"Acta Radiol"},{"key":"12195_CR25","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.12659\/MSM.893018","volume":"21","author":"E Luczynska","year":"2015","unstructured":"Luczynska E, Heinze-Paluchowska S, Hendrick E et al (2015) Comparison between breast MRI and contrast-enhanced spectral mammography. Med Sci Monit 21:1358\u20131367","journal-title":"Med Sci Monit"},{"key":"12195_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/RCT.0000000000000832","volume":"43","author":"D Xing","year":"2019","unstructured":"Xing D, Lv Y, Sun B et al (2019) Diagnostic value of contrast-enhanced spectral mammography in comparison to magnetic resonance imaging in breast lesions. J Comput Assist Tomogr 43:245\u2013251","journal-title":"J Comput Assist Tomogr"},{"key":"12195_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.110881","volume":"164","author":"MBI Lobbes","year":"2023","unstructured":"Lobbes MBI, Neeter LMFH, Raat F et al (2023) The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer. Eur J Radiol 164:110881","journal-title":"Eur J Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-12195-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:22:11Z","timestamp":1776338531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-12195-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["12195"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-12195-8","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is M.L.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"M.L. received research funding from GE Healthcare, Hologic Inc., and Sirius Medical B.V. M.L. received honorary fees for presentations and participation of medical advisory boards from GE Healthcare, Hologic Inc., Sirius Medical B.V., Bayer, Guerbet, and Tromp Medical B.V. J.W. received institutional grants from Abbott, Anaconda Biomed, Asklepios, Bayer, Becton & Dickinson medical, Bentley, Boston, Brainlab, GE Healthcare, Gleamer, Hologic, Inari Medical, Johnson & Johnson, Merit Medical Systems, Nico-Lab, Medtronic, Microvention, Nova Techs, Oldelft Benelux, Ontario Associatino of Radiologists, Penumbra, Philips, Siemens, Stryker, Tajpan Sro. L.N., K.D., F.R., M.S., and B.E. had no conflicts of interest to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (B.E.) has a background in Health Technology Assessment and experience with conducting and analysing trial-based economic evaluations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained (METC171082\/NL62788.068.17).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study protocol and clinical outcomes of the RACER trial have already been published and are available via Open Access.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}